GÜVEN, D. C. Et Al. 2024. The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors: A Turkish oncology group (TOG) study. CANCER MEDICINE , vol.13, no.1 .

GÜVEN, D. C., Aykan, M. B., MUĞLU, H., BAYRAM, E., Helvaci, K., Dursun, B., ... Celayir, M.(2024). The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors: A Turkish oncology group (TOG) study. CANCER MEDICINE , vol.13, no.1.

GÜVEN, DENİZ Et Al. "The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors: A Turkish oncology group (TOG) study," CANCER MEDICINE , vol.13, no.1, 2024

GÜVEN, DENİZ C. Et Al. "The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors: A Turkish oncology group (TOG) study." CANCER MEDICINE , vol.13, no.1, 2024

GÜVEN, D. C. Et Al. (2024) . "The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors: A Turkish oncology group (TOG) study." CANCER MEDICINE , vol.13, no.1.

@article{article, author={DENİZ CAN GÜVEN Et Al. }, title={The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors: A Turkish oncology group (TOG) study}, journal={CANCER MEDICINE}, year=2024}